Relationship between insulin resistance and plasma vitamin D in adults

Diabetes, Metabolic Syndrome and Obesity

Volumn 7, Issue , 2014, Pages 297-303

  Badawi, Alaa ^a   Sayegh, Suzan ^b   Sadoun, Eman ^b   Al Thani, Mohamed ^b   Arora, Paul ^c   Haddad, Pierre S ^d  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b Supreme Council of Health   (Qatar)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Diabetes; HOMA IR; Plasma 25(OH)D

Indexed keywords

25 HYDROXYVITAMIN D;

ADOLESCENT; ADULT; AGED; ARTICLE; CANADA; DISEASE ASSOCIATION; FEMALE; HUMAN; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; VITAMIN BLOOD LEVEL;

EID: 84904036001     PISSN: None     EISSN: 11787007     Source Type: Journal    
DOI: 10.2147/DMSO.S60569     Document Type: Article

References (42)

1. Rathmann W, Giani G. Global prevalence of diabetes: estimates for the year 2000 and projection for 2030. Diabetes Care. 2004;27(10): 2568-2569.
2. Comeau P. New diabetes treatment and prevention strategies needed. CMAJ. 2007;176(10):1401-1402.
3. Moore AF, Florez JC. Genetic susceptibility to type 2 diabetes and implications for antidiabetic therapy. Annu Rev Med. 2008;59: 95-111.
4. Swenne I. Pancreatic beta-cell growth and diabetes mellitus. Diabetologia. 1992;35(3):193-201.
5. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell defcit and increased beta-cell apoptosis in hu mans with type 2 diabetes. Diabetes. 2003;52(1):102-110.
6. Badawi A, Klip A, Haddad P, et al. Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention. Diabetes Metab Syndr Obes. 2010;3:173-186.
7. Deleskog A, Hilding A, Brismar K, Hamsten A, Efendic S, Östenson CG. Low serum 25-hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance. Diabetologia. 2012;55(6):1668-1678.
8. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79(5):820-825.
9. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan J P. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286(10):1195-1200.
10. Badawi A, Garcia-Bailo B, Arora P, Al-Thani MH, Sadoun E, Farid M, El-Sohemy A. The utility of vitamins in the prevention of type 2 diabetes mellitus and its complications: A public health perspective. In: Oguntibeju O, editor. Diabetes Mellitus - Insights and Perspectives. Rijeka: InTech Publ; 2013;1-16. Doi: 10.5772/47834.
11. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among US adults. Diabetes Care. 2005;28(5):1228-1230.
12. Hyppönen E, Power C. Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care. 2006;29(10):2244-2246.
13. Need AG, O'Loughlin PD, Horowitz M, Nordin BE. Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clin Endocrinol (Oxf). 2005;62(6):738-741.
14. Brenner DR, Arora P, Garcia-Bailo B, et al. Plasma vitamin D levels and risk of metabolic syndrome in Canadians. Clin Invest Med. 2011;34(6):E377-E384.
15. Da Costa LA, Arora P, García-Bailo B, Karmali M, El-Sohemy A, Badawi A. The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related infammation in Canadian adults. Diabetes Metab Syndr Obes. 2012;5:347-355.
16. Liu S, Song Y, Ford ES, Manson JE, Buring JE, Ridker PM. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older US women. Diabetes Care. 2005;28(12): 2926-2932.
17. Gulseth HL, Gjelstad IM, Tierney AC, et al. Serum vitamin D concentration does not predict insulin action or secretion in European subjects with the metabolic syndrome. Diabetes Care. 2010;33(4):923-925.
18. García-Bailo B, Da Costa LA, Arora P, Karmali M, El-Sohemy A, Badawi A. Plasma vitamin D and biomarkers of cardiometabolic disease risk in adult Canadians, 2007-2009. Prev Chronic Dis. 2013;10:E91.
19. Badawi A, Arora P, Sadoun E, Al-Thani A, Al-Thani MH. Prevalence of vitamin D defciency in Qatar: a systematic review. J Pub Health Res. 2012;1(3):229-235.
20. García-Bailo B, Roke K, Mutch DM, El-Sohemy A, Badawi A. Association between circulating ascorbic acid, α-tocopherol, 25- hydroxyvitamin D, and plasma cytokine concentrations in young adults: a cross-sectional study. Nutr Metab (Lond). 2012;9(1):102.
21. Garcia-Bailo B, El-Sohemy A, Haddad P, Arora P, BenZaied F, Karmali M, Badawi A. Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: modulation of infammation and oxidative stress. Biologics. 2011;5:7-19.
22. Baier LJ, Dobberfuhl AM, Pratley RE, Hanson RL, Bogardus C. Variations in the vitamin D-binding protein (Gc locus) are associated with oral glucose tolerance in nondiabetic Pima Indians. J Clin Endocrinol Metab. 1998;83(8):2993-2996.
23. McDermott MF, Ramachandran A, Ogunkolade B W, et al. Allelic variation in the vitamin D receptor infuences susceptibility to IDDM in Indian Asians. Diabetologia. 1997;40(8):971-975.
24. Pani MA, Knapp M, Donner H, et al. Vitamin D receptor allele combinations infuence genetic susceptibility to type 1 diabetes in Germans. Diabetes. 2000;49(3):504-507.
25. Malecki MT, Klupa T, Wolkow P, Bochenski J, Wanic K, Sieradzki J. Association study of the vitamin D: 1alpha-hydroxylase (CYP1alpha) gene and type 2 diabetes mellitus in a Polish population. Diabetes Metab. 2003;29(2 Pt 1):119-124.
26. García-Bailo B, Jamnik J, Da Costa LA, Badawi A, El-Sohemy A. Genetic variation in the vitamin D receptor, plasma 25-hydroxyvitamin D, and biomarkers of cardiometabolic disease in Caucasian young adults. J Nutrigenet Nutrigenomics. 2013;6(4-5):256-267.
27. Beaulieu C, Kestekian R, Havrankova J, Gascon-Barré M. Calcium is essential in normalizing intolerance to glucose that accompanies vitamin D depletion in vivo. Diabetes. 1993;42(1):35-43.
28. Teegarden D, Donkin SS. Vitamin D: emerging new roles in insulin sensitivity. Nutr Res Rev. 2009;22(1):82-92.
29. Tremblay MS, Connor Gorber SC. Canadian health measures survey: brief overview. Can J Public Health. 2007;98(6):453-456.
30. Giroux S. Canadian Health Measures Survey: sampling strategy overview. Health Rep. 2007;18 Suppl:31-36.
31. Health Canada. Health Risk Classifcation According to Body Mass Index (BMI); 2003. Available from: www.hc-sc.gc.ca/fn-an/nutrition/weights-poids/guide-ld-adult/cg_quick_ref-ldc_rapide_ref-table1-eng.php. Accessed June 6, 2014.
32. Kayaniyil S, Vieth R, Retnakaran R, et al. Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care. 2010;33(6):1379-1381.
33. Scragg R, Sowers M, Bell C; Third National Health and Nutrition Examination Survey. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004;27(12):2813-2818.
34. Haden ST, Brown EM, Hurwitz S, Scott J, El-Hajj Fuleihan G. The effects of age and gender on parathyroid hormone dynamics. Clin Endocrinol (Oxf). 2000;52(3):329-338.
35. Bourlon PM, Billaudel B, Faure-Dussert A. Influence of vitamin D3 deficiency and 1,25 dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. J Endocrinol. 1999;160(1): 87-95.
36. Maestro B, Campión J, Dávila N, Calle C. Stimulation by 1,25- dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J. 2000;47(4):383-391.
37. Chacko SA, Song Y, Manson JE, et al. Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. Am J Clin Nutr. 2011;94(1): 209-217.
38. Del Gobbo LC, Song Y, Dannenbaum DA, Dewailly E, Egeland GM. Serum 25-hydroxyvitamin D is not associated with insulin resistance or beta cell function in Canadian Cree. J Nutr. 2011;141(2):290-295.
39. Whiting SJ, Langlois KA, Vatanparast H, Greene-Finestone LS. The vitamin D status of Canadians relative to the 2011 Dietary Reference Intakes: an examination in children and adults with and without supplement use. Am J Clin Nutr. 2011;94(1):128-135.
40. Vatanparast H, Calvo MS, Green TJ, Whiting SJ. Despite mandatory fortification of staple foods, vitamin D intakes of Canadian children and adults are inadequate. J Steroid Biochem Mol Biol. 2010;121(1-2): 301-303.
41. Freedman BI, Register TC. Effect of race and genetics on vitamin D metabolism, bone and vascular health. Nat Rev Nephrol. 2012;8(8): 459-466.
42. Brenner DR, Arora P, Garcia-Bailo B, El-Sohemy A, Karmali M, Badawi A. The relationship between metabolic syndrome components and inflammatory markers among non-diabetic Canadian adults. J Diab Metabol. 2011;S2:003. Doi: 10.4172/2155-6156.